06-11-2020

 Bold Therapeutics Expands COVID-19 Consortium 

---

06-11-2020

 Bold Therapeutics Expands COVID-19 Consortium 

---

05-28-2020

Bold Therapeutics and Hana Pharm Execute Option Agreement for Exclusive Development and Commercialization Rights to BOLD-100 in South Korea

---

04-15-2020

Bold Therapeutics and the University of Ottawa Initiate Research Partnership to Study BOLD-100 in the Treatment of COVID-19

---

03-27-2020

Bold Therapeutics Seeks Collaborators for Rapid Development of BOLD-100; Lead Drug Candidate Has Potential Utility in the Treatment of COVID-19

---

03-27-2020

Bold Therapeutics to Initiate Phase 1b Trial of BOLD-100 in GI Cancers

---

02-10-2020

Bold Therapeutics Visiting Collaborators in Europe

---